T lymphocytes undergo apoptosis in response to a variety of stimuli, including glucocorticoids, radiation, withdrawal of growth factors, activation, viral infection, and some chemotherapeutic agents (1) . Immature thymocytes and T cell hybridomas die by apoptosis when they were activated via the TCR, as do already activated mature peripheral T cells (2) (3) (4) . The activation-induced death of thymocytes is an important component of negative selection, and therefore the establishment of tolerance to self antigens. Activationinduced apoptosis of mature T ceils is thought to be at least one mechanism of maintaining peripheral tolerance and, perhaps, of limiting an ongoing immune response. In addition to these physiological examples of T cell apoptosis, inappropriate apoptosis of peripheral T cells from individuals infected with HIV has been observed, prompting the speculation that this phenomenon may play a role in the loss of CD4 + T cells and the immunodeficiency that characterizes AIDS (5-9).
T cell hybridomas have been widely used in the investigation of cell death induced by specific antigen or anti-TCR antibodies. Activation of T cell hybridomas leads to a rapid G1/S cell cycle block (growth arrest), followed by apoptosis, which occurs after a period of 4-8 h (2, 3, 10) . Although the mechanism of activation-induced apoptosis is not well understood, clues have been gleaned from studies using a variety of chemical and biological agents. Cycloheximide and actinomycin D prevent activation-induced apoptosis in T cell hybridomas, indicating a requirement for new protein biosynthesis (10, 11) . Inhibitors of T cell activation and IL-2 production, such as cyclosporin A (CsA) 1 or depletion of extracellular Ca 2+, also block apoptosis. Dexamethasone, which itself induces apoptosis ofT cell hybridomas and thymot Abbreviations used in this paper: CsA, cyclosporin A; Dex, dexamethasone; FasL, ligand for Fas.
cytes, paradoxically prevents activation-induced death (12) . One can distinguish between activation-induced pathways leading to IL-2 production or cell death, however, with compounds such as retinoic acid and protease inhibitors, which prevent activation-induced apoptosis but have little effect on activation-induced IL-2 production (13) (14) (15) .
Another cell surface molecule implicated in lymphocyte apoptosis is Fas, also known as APO-1 or CD95. Fas is a transmembrane molecule belonging to the TNF/nerve growth factor receptor superfamily (16, 17) , and its multivalent crosslinking with antibody rapidly induces apoptosis in both normal and transformed lymphocytes. The ligand for Fas, FasL, has recently been identified and cloned (18) , and is a type II transmembrane protein that is a member of the TNF superfamily. Binding of FasL to Fas results in rapid apoptosis of the Fasexpressing cells (18) . T cells from Fas-deficient IFr mice and FasL-deficient gld mice have a defect in antigen-stimulated apoptosis, strongly supporting the notion that Fas is involved in activation-induced T cell apoptosis (19) . We have studied the requirement for Fas and FasL in the activation-induced cell death in T cell hybridomas, and find that these molecules are key components of this process. Both the requirement for cellular activation, and inhibition of death by retinoic acid and glucocorticoids, can be explained by the regulated expression of FasL and its interaction with Fas.
Materials and Methods
Cells and Reagents. 2B4.11 is a murine T cell hybridoma specific for peptide 81-104 of pigeon cytochrome c (2). 21.2.2 is a variant of 2B4.11 that lacks TCR cr and therefore does not express cell surface CD3 (20) . PC60-dllS (dllS), L1210 (leukemia ceil line), and L1210-Fas + (L1210 cells transfected withJas) cells were kindly provided by Dr. P. Golstein (21) . Cells were cultured and assayed in ILPMI 1640 (Biofluids Inc., Rockville, MD) supplemented with 10% heat-inactivated FCS, 4 mM glutamine, 100 U/ml penicillin, 150 #g/ml gentamicin, and 5 x 10 -s M 2-mercaptoethanol. 145-2Cll (2Cll) is a hamster monoclonal antibody against mouse CD3-~ (22) , and was purified from culture supernatant by affinity chromatography with protein A-sepharose. The anti-mouse Fas antibody Jo2 and PE-labeled Jo2 were purchased from PharMingen (San Diego, CA), and PE-anti human CD8 was purchased from (Biosource International, Camarillo, CA). The anti-mouse Fc receptor antibody 2.4G2 (23) was purified from culture supernatant. Dexamethasone (Dex), PMA, and ionomycin were purchased from Sigma Immunochemicals (St. Louis, MO). 9-cis retinoic acid was the generous gift of Dr. R. Heyman (Ligand Pharmaceuticals, La Jolla, CA).
DNA Fragmentation Assay. DNA fragmentation was quantitated by adherence to fiberglass filters, as described (14) . Briefly, cells were incubated with [3H]thymidine (5/~Ci/ml) for 3 h and then distributed in triplicate into 96-well microtiter plates. Unless otherwise indicated, 5 x 104 T cells were plated per well. After culture for the indicated times the cells were hypotonically lysed and harvested onto fiberglass falters (PHI) Cell Harvester; Cambridge Technology, Cambridge, MA). Intact chromatin adheres to the falters, but DNA fragments pass through. The results are expressed as specific DNA fragmentation:
M-E --x 100 M where M = retained label in cells cultured in medium, and E = retained label in cells cultured under experimental conditions, _+ the standard error of the mean. In cell mixing experiments the number of labeled "target" cells was held constant at 2.5 x 104 cells per well and the number of "effector" cells was varied from 1.25 x 104 to 1.25 x 105 cells per well.
IL2 Assay. Aliquots of supernatant were removed and assayed for Ib2 as described (24) . An IL-2 unit is defined as the dilution of supernatant that caused IL-2-dependent CTLL-2 cells to incorporate half-maximal amounts of [3H]thymidine. Activation of d11S Cells. d11S cells were activated with PMA (10 ng/ml) plus ionomycin (3/zg/ml) for 3 h to induce expression of FasL, as described (21) .
Growth Inhibition
Flow Cytometry. Specific staining was performed with PE-Jo2.
Phycoerythrin-conjugated mouse anti-human CD8 was used as a negative control. Flow cytometric analysis was performed with a FACScan (Becton-Dickinson, CA).
Receptor Fc Constructs. A cDNA encoding the extracellular domain of Fas was isolated by PCR from the II-23.D7 human T cell hybridoma (25) . This fragment was ligated in frame to a 710-bp cDNA fragment encoding the hinge, CH2 and CH3 domains of human IgG1 and subcloned into pDC302. For construction of the baculovirus transfer vector, a double stranded linker was designed with an internal EcoR1 site and a KpnI overhang with the sequence 5'-CACAATTCGGGTAC-3' and for the bottom strand 5'-CCG-AATTCTC-3'. The bottom strand was treated with T4 polynucleotide kinase before annealing to the linker and subsequent ligation to the Fas:Fc KpnI/NotI site of the baculovirus transfer vector, pV1393 (Invitrogen, San Diego, CA). The TNFR60:Fc chimera, composed of the extracellular domain of the 55-60-kD TNF receptor and the Fc portion of human IgG1, was constructed as described (26) . Tn5B1-4 cells were infected with recombinant baculovirus in serum-free medium and the proteins purified to homogeneity by affinity chromatography using a protein G-Sepharose 4BCL resin.
Northern Blot Analysis. 2B4.11 cells (15 x 106 per point) were cultured in tissue culture dishes (Falcon 3003; Becton Dickinson Labware, Lincoln Park, NJ) that were coated with medium alone or anti-CD3 (10/zg/ml). After culture for the indicated times, RNA was prepared by a modified guanidine thiocyanate method (27) . cDNA of the extracellular portion of mouse FasL was kindly provided by Dr. B. Niklinska (National Cancer Institute, National Institutes of Health, Bethesda, MD), and was obtained by PCR using the primers GGA ATT CAT GCA GCT CTT CCA GAC AGA AGG A and CGG GAT CCT TAA AGC TTA TAC AAG CCG AAA AAG, and purified from agarose gel using the Geneclean II kit (Bio 101, Inc., Viata, CA). The Pst fragment of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was kindly provided by Drs. F. Mushinski and L. King (National Cancer Institute, National Institutes of Health). The probes were labeled with 32p using the random primer labeling kit from Stratagene (La Jolla, CA). 15 #g of total RNA, as determined by UV absorption, was loaded into each well and electrophoresed through a 1.0% agarose gel. After transfer to nitrocellulose, hybridization was carried out using QuikHyb solution and procedures suggested by the manufacturer (Stratagene Inc., San Diego, CA). After exposure to detect FasL, the blots were stripped twice with boiling 0.1x SSC and 0.1% SDS buffer, and then reblotted for GAPDH.
Results

Characterization of a "Deathless" Variant of the 2B4.11 T Cell
Hybridoma. Activation of T cell hybridomas via the TCR results in II,-2 production, a Gt/S cell cycle block, and apoptosis (2, 3, 10, 28 ). There appears to be more than one signaling pathway for these responses, since activation-induced apoptosis and ID2 production require extracellular Ca 2+ and are inhibited by CsA, while the cell cycle block does not require extracellular Ca z+ and is CsA resistant (28) . In an attempt to obtain T cell hybridoma variants that do not die when activated, 2B4.11 T hybridoma cells were cultured at a density of 104 per microtiter well with 5 x 105 B10.A irradiated spleen cells (as a source of antigen-presenting cells) and 30/zM pigeon cytochrome c fragment 81-I04. As shown in Fig. 1 , cells that grew from one well, termed VD1 cells, did not die when restimulated with anti-CD3 ( Fig. 1 A) . VD1 cells also did not die when the antigen for which it is specific, pigeon cytochrome c, was used as a stimulus (data not shown). In contrast to the failure to undergo activationinduced apoptosis, stimulation of VD1 cells with anti-CD3 resulted in two other discrete biological responses that were quantitatively indistinguishable from those of the wild-type cells: IL-2 production and growth inhibition, the latter being mainly a manifestation of the G1/S cell cycle block (Fig. 1 , B and C) (28) . Therefore, although biological responses that are mediated by several distinct TCR-mediated signaling pathways are intact in VD1 cells, activation-induced apoptosis is not.
Analysis of Fas in 2B4.11 and VDI Cell. 2B4.11 and VD1
cells were analyzed for a variety of functionally important cell surface molecules, and were found to express comparable levels TCR, Ly-6, Thy-1, CD45, CD4, and CD8 (both cells being negative for the latter two). There was a difference, however, in expression of Fas. As shown in Fig Since Fas is a receptor that transduces signals leading to death, we asked how 2B4.11 and VD1 ceils would respond when cultured with FasL + effector cell. d11S is a subclone of a rat-mouse T cell hybridoma whose expression of cell surface FasL increases after activation with PMA and ionomycin (21) . As previously shown (21) , unactivated d11S caused a small amount of apoptosis in 2B4.11 cells, and its activation with PMA and ionomycin greatly enhanced this activity (Fig. 3 A) . The killing was mediated by Fas, since the Jo2 anti-Fas monoclonal antibody blocked the killing of the 2B4.11 cells (note that soluble Jo2 does not kill 2B4.11 cells since it is an IgG, and bivalent binding of Fas is insufficient to induce death [29] ). In contrast to 2B4.11 cells, VD1 cells were not killed by d11S, even when the effector cells were activated with PMA and ionomycin (Fig. 3 B) . Thus, just as when they are activated via the TCR, VD1 cells do not die when signaled through Fas. cells to be killed by FasL-bearing effector cells raised the possibility that activation-induced death, to which VD1 is resistant, is mediated by Fas. To determine if Fas is involved in activation-induced apoptosis, the Jo2 anti-Fas antibody was added to 2B4.11 cells that were or were not activated with anti-CD3 (Fig. 4) . Immobilized anti-CD3 antibody alone caused -035% specific DNA fragmentation of 2B4.11 cells. The activation-induced DNA fragmentation was completely prevented by anti-Fas antibody in a dose-dependent fashion, with complete inhibition achieved at 150 ng/ml (Fig. 4 A) . In contrast to its inhibition of apoptosis, the Jo2 antibody had no effect on activation-induced IL-2 production (Fig. 4  B) . Glucocorticoids also induce apoptosis in T cell hybridomas, but by a pathway that is distinct from that of activation (12) . To determine the specificity of anti-Fas inhibition of apoptosis, Jo2 was added to 2B4.11 cells treated with increasing concentrations of Dex (Fig. 4 C) . Unlike activation via the TCR, addition of anti-Fas antibody had no effect on DNA fragmentation caused by Dex. Another response to activation, growth arrest, was also measured. Anti-Fas antibodies did not prevent activation-induced inhibition of transformed growth (Fig. 5) . Together with the failure to block IL-2 production, these results indicate that anti-Fas did not interfere with activation per se, just with the apoptotic response to activation. this soluble molecule would have on activation-induced T cell apoptosis (Fig. 6 ). Anti-CD3 induced ,,o55% specific DNA fragmentation, which was inhibited by soluble Fas:Fc in a concentration-dependent manner, with maximal inhibition achieved at 10/zg/ml. As a control, a chimeric molecule consisting of the extracellular portion of the Fas-related TNF receptor and the Fc portion of human IgG1 (TNFP~60:Fc) was added to activated 2B4.11 cells. Unlike Fas:Fc, this molecule had no effect on activation-induced death. Anti-Fas (ng/ml) Anti-Fas (ng/ml) 10ex (Log M) even at a concentration of 20 #g/ml. As with the anti-Fas antibody, Fas:Fc did not prevent activation-induced growth inhibition or IL-2 production (data not shown).
Activation-induced Death of T Cell Hybridoma Is Blocked by
Expression of Fas and FasL on T Cell Hybridomas. FasL has
been reported to be highly expressed on activated but not resting T cells (18) . Since Fas itself is constitutively expressed on 2B4.11 cells and its levels were unaffected by activation, it seemed likely that the activation-regulated expression of FasL might account for the apoptotic response to stimulation via the TCK. FasL mRNA expression was measured by Northern blot analysis. No FasL mRNA was detected in unstimulated 2B4.11 cells (Fig. 7 A) . However, as early as (Fig. 8) T C R because it lacks T C R oe and 3 chains (20) . As shown in Fig. 9 A, 2B4.11 but not 21.2.2 cells died in a stimulusdependent manner when cultured in wells coated with anti-CD3 antibodies. As shown for 2B4.11, T C R -21.2.2 are also susceptible to Fas-mediated killing, since coculture with d11S cells resulted in their death, which was inhibited by antiFas antibodies (Fig. 9 B) . In Fig. 9 C, 
Retinoic Acid and Dexametkasone Prevent Activation-induced
FasL Up-regulation. Both retinoic acid, especially the 9-c/s stereoisomer, and glucocorticoids inhibit activation-induced apoptosis of T cell hybridomas (12) (13) (14) . Experiments were performed to determine if the biological activity of either of these reagents is due to effects on the regulation of FasL expression. 9-C/s retinoic acid completely prevented, and Dex greatly reduced, the activation-induced increase in FasL m R N A in 2B4.11 cells (Fig. 7 B) . These decreases in FasL m R N A were reflected in the biological activity of this molecule, since 2B4.11 cells that were stimulated with anti-CD3 antibody in the presence of 9-c/s retinoic acid (10 -6 M) or Dex (1 #M) did not induce the death of L1210-Fas cells (Fig.  10 ). This effect on cytotoxicity was at the level of effector 2B4.11 cell generation, because addition of retinoic acid or Dex to L1210-Fas cells at the time of adding activated 2B4.11 cells had no effect on Fas-mediated cell death (Fig. 10) . 
D i s c u s s i o n
Fas is a 48-kD transmembrane molecule that belongs to the TNF/nerve growth factor receptor gene superfamily, which also includes CD27, CD40, CD30, and OX40 (16, 17, 32) . Mouse Fas m R N A is expressed in thymus, liver, heart, lung, and ovary; it is undetectable in spleen, brain, kidney, and bone marrow (32). Fas is not expressed by the majority of human peripheral blood T cells unless they have been activated (33) (34) (35) . It is expressed at high levels on human CD4 + CD8 + T C R intermediate thymocytes, decreasing in level as the cells mature to the T C R hi stage (36) . Two groups independently identified Fas as a signaling molecule whose cross-linking with antibody can lead to death (33, 37) . Until recently little was known about how ligation of Fas leads to death. Mutational analysis has shown that an intracellular domain that is homologous to a region in the TNF receptor is required for Fas-mediated killing (29) . However, the intracellular portion of the molecule has no consensus sequences for kinases or phosphatases. It has recently been demonstrated that cross-linking of Fas on a variety of human cell lines induces the activity of an acid sphingomyelinase, which results in the generation of ceramide, and that exogenous addition of the cell-permeable C2-ceramide induces apoptosis in these cells (38) . This mechanism has also been suggested for cell cule is 38,000-42,000, the larger molecular size probably being due to N-linked glycosylation. FasL is homologous to the TNF family of molecules. Cells transfected with FasL cDNA, but not control cells, were able to kill Fas + targets. Interestingly, supernatants of COS cells transfected with FasL cDNA were also able to kill Fas + targets, suggesting that FasL can be shed in an active form. Rat FasL mRNA has a very different tissue distribution from Fas, being expressed in small intestine, testis, lung, and spleen. Of particular interest is that activation of spleen cells or thymocytes induces expression of FasL, indicating that activated T cells can express both Fas and FasL (18) . Human and mouse FasL are highly homologous, and human and mouse FasL bind to Fas from either species (30) .
Our data demonstrate that, as for the majority of thymocytes, the 2B4.11 T cell hybridoma constitutively expresses Fas, and cellular activation induces expression of FasL. The interaction of this receptor-ligand pair is required for activationinduced apoptosis of these cells. VD1 cells, which were selected by virtue of their resistance to TCR-mediated activationinduced death, have very low levels of Fas but normal levels of functional FasL upon activation. We believe that the low level of Fas on VD1 is sufficient to account for its resistance to FasL-or activation-induced death, since the level of Fas on these cells is comparable to, or even less than, the levels of Fas on L1210 cells. It is possible, however, that in addition to lower than normal expression, Fas may be mutated and nonfunctional in VD1 cells, or there may be defects in other components of the Fas-mediated signaling pathway. Further evaluation of Fas and its signaling pathway(s) in VD1 cells should allow us to distinguish between these possibilities.
Pharmacological agents such as retinoic acid and glucocorticoids are able to block activation-induced apoptosis of T cells. The data in the present paper show that both of these agents prevent the up-regulation of FasL, but have no effect on killing signaled through Fas by effector cells that are already FasL +. Both of these molecules mediate their effects by binding ligand-regulated nuclear transcription factors. Therefore, the simplest mechanism by which they might affect FasL expression would be for their respective receptors/transcription factors to directly regulate FasL gene transcription. An analysis of '-300 bp 5' of the ATG initiation codon of human FasL has found regulatory elements for SP-1, NF-KB, and IRF-1 (30) . There are no obvious retinoic acid response elements or glucocorticoid response elements in this region. Such response elements may be found in more distal flanking regions of the gene, or possibly in intronic sequences. Alternatively, glucocorticoids and/or retinoic acid may exert their effects on FasL by an indirect mechanism. We have also found that CsA, which prevents Ca2+-dependent activation events by inhibiting the phosphatase calcineurin (40, 41) and inhibits activation-induced apoptosis but not the G1/S cell cycle block (28) , also prevents activation-induced up-regulation of FasL (our unpublished observation). Therefore, a variety of agents that mediate their protective effects by interacting with different DNA-regulatory sites or proteins have in common the ability to suppress FasL expression.
In the present study we found that activated 2B4.11 cells were able to kill unactivated 2B4.11 cells in a Fas-dependent manner. We have previously shown that when T cell hybridomas with different antigen specificities are cocultured in the presence of one antigen, only the growth of the activated cell is inhibited (2) . That is consistent with the finding in the present report in that the GffS block induced by activation does not seem to be Fas dependent: unlike apoptosis, growth inhibition was not reversed by anti-Fas antibodies. Another study, in which only one of two cocultured T cell hybridomas was specifically activated, detected only a small amount of bystander killing (of 2B4.11 cells) as measured by release of fragmented DNA, which was interpreted as indicating a lack of bystander killing (10). However, in that experiment the total time of stimulation was only 8 h, compared to 16 h of coculture in the present report. FasL must be up-regulated before activated cells can act as effectors, and by Northern blot analysis it takes 4-6 h to achieve high levels of expression. We have found that at shorter times of coculture Fas-dependent bystander killing is more difficult to detect (data not shown), indicating that killing in trans may be less effident that killing in cis. This may be because Fas-FasL interactions are more effective if both molecules are present on the same cell. Alternatively, just as with FasL-expressing COS cells (18) , FasL may be shed from activated cells and preferentially interact with Fas molecules on the same cell.
The biological importance of Fas and FasL in normal T cell biology is demonstrated by the phenotypes of lpr and gld mice, which have defects in expression of Fas and FasL, respectively (42, 43) . The major pathological changes in these mice are accumulation of CD4-CD8-TCR + T cells (lymphoproliferation) and autoimmunity (44) . It has been suggested that the accumulating aberrant T cells originate from "neglected" CD4 + CD8 +TCR auu thymocytes that escape to the periphery due to absence of Fas (45) . However, although the thymus expresses the highest level of Fas mRNA among normal tissues, and activation of thymocytes induces FasL mRNA, the development of thymocytes appears to be normal in lpr mice (46, 47) . More recently, using transgenic TCR crossed with MRL-lpr/1pr or control MRL +/+ mice, it has been possible to demonstrate a role for Fas in peripheral but not thymic deletion of T lymphocytes (48) . This observation is supported by experiments that show activation-induced apoptosis of peripheral T cells depends on Fas and FasL (19, (49) (50) (51) . Thus, at this time, it appears that Fas/FasL plays a critical role in peripheral T cell deletion, It is interesting to note that degree of T cell hybridoma apoptosis induced with a mitogenic anti-Thy-1 antibody varies with the maturity of the T cell fused to the BW5147 murine thymoma: fusions made with immature thymocytes are resistant to killing, while those made with peripheral T cells are sensitive (11) . This may suggest that the T ceil hybridoma phenotype, with regard to activation-induced apoptosis at least, reflects a pathway present in mature, but not immature, T cells, which is consistent with our present understanding of the biological role of Fas and FasL in regulated T cell death.
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